SMS Pharmaceuticals Limited
SMS Pharmaceuticals Ltd is a diversified and integrated pharmaceutical company with interests in Active Pharmaceutical Ingredients (API) and Intermediates.
What SMS files
- Others61
- Important24
- Updates24
- Investor Meet12
- Pledging11
- Board Meeting8
SMS Pharmaceuticals Limited has announced participation in a group analyst and institutional investor meeting at Hyderabad with Emkay Global. Discussions will focus strictly on industry and company developments already in the public domain, ensuring no unpublished price-sensitive information is shared.
SMS Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
SMS Pharma is holding its 38th AGM where the FY25-26 Annual Report will be presented. The company proposes a dividend of Rs 0.40 per share. Shareholders are advised to update KYC for timely electronic dividend payouts.
SMS Pharma filed its Business Responsibility and Sustainability Report for FY2025-26. Key initiatives include a new `1.9 Cr` CAPEX for advanced effluent treatment, commissioning a 1.3 MW rooftop solar project, and enhancing solvent recovery by 45-50%, significantly cutting hazardous waste. Local sourcing reduced transport-related GHG emissions by ~21 tCO2e.
SMS Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2026